Doximity, Inc. DOCS
Deals with insiders in the proxy filed Jul 15, 2026
Proxy, Item 404Deals between DOCS and its directors, executives, owners of more than 5% or their families: a relative on the payroll, a plane the company charters from its CEO, a director's company that buys from it. SEC rules (Item 404) make the company list every such deal over $120,000 in its proxy statement.
New this year
Compared with Jul 16, 2025
Paragraphs about a deal, a person or a relative with nothing like them in the proxy filed Jul 16, 2025.
Consulting Agreement“On September 12, 2025, the Company entered into a consulting agreement (the "Benjamin Consulting Agreement") with Dr. Regina Benjamin, a member of our Board of Directors, pursuant to which Dr. Benjamin agreed to provide strategic advisory services to the Company in connection with PeerCheck™, the physician-led verification layer within the Company's Ask AI assistant that is designed to review and validate AI-generated responses. We believe Dr. Benjamin brings uniquely valuable experience as Former United States Surgeon General, her leadership experience with the American Medical Association, her significant regulatory and policy expertise, as well as her experience with rural healthcare systems to serve as co-editor-in-chief of our company’s PeerCheck™ initiative, which will embed physician review into Doximity Ask, Doximity’s evidence-based AI tool. Our immediate goal is to bring more trust and transparency to AI outputs by allowing physicians to evaluate and improve AI-generated answers for accuracy, evidence strength, and potential bias. Long term, our aim is for PeerCheck™ to serve as a model for how medical AI should be built and governed. The Benjamin Consulting Agreement has an initial term of November 2025 through May 15, 2028 and provides for compensation consisting of RSUs with an aggregate value of approximately $2,000,000 in consideration for the consulting services to be provided under the agreement. See “Compensation of Non-Employee Directors - Consulting Arrangements with Certain Directors” for additional information.”
Read it in the proxyopen_in_new
The whole section
As filed
16 paragraphs quoted as filed
CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS“In addition to the compensation arrangements, including employment, termination of employment and change in control arrangements and indemnification arrangements, discussed, when required, in the sections titled “Executive Officers” and “Executive Compensation” the following is a description of each transaction during fiscal year 2026 and each currently proposed transaction in which:”
Read it in the proxyopen_in_new
CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS“the amount involved exceeded or exceeds $120,000; and • any of our directors, executive officers or holders of more than 5% of our capital stock, or any immediate family member of, or person sharing the household with, any of these individuals, had or will have a direct or indirect material interest.”
Read it in the proxyopen_in_new
Investors’ Rights Agreement“We are party to an investors’ rights agreement which provides, among other things, that certain holders of our capital stock have the right to demand that we file a registration statement or request that their shares of our capital stock be covered by a registration statement that we are otherwise filing. The parties to the investors’ rights agreement include Jeff Tangney, our Chief Executive Officer and a current director, and entities affiliated with Mr. Tangney and entities affiliated with InterWest Partners, Emergence Capital Partners, and Morgenthaler Ventures.”
Read it in the proxyopen_in_new
Consulting Agreement“On September 12, 2025, the Company entered into a consulting agreement (the "Benjamin Consulting Agreement") with Dr. Regina Benjamin, a member of our Board of Directors, pursuant to which Dr. Benjamin agreed to provide strategic advisory services to the Company in connection with PeerCheck™, the physician-led verification layer within the Company's Ask AI assistant that is designed to review and validate AI-generated responses. We believe Dr. Benjamin brings uniquely valuable experience as Former United States Surgeon General, her leadership experience with the American Medical Association, her significant regulatory and policy expertise, as well as her experience with rural healthcare systems to serve as co-editor-in-chief of our company’s PeerCheck™ initiative, which will embed physician review into Doximity Ask, Doximity’s evidence-based AI tool. Our immediate goal is to bring more trust and transparency to AI outputs by allowing physicians to evaluate and improve AI-generated answers for accuracy, evidence strength, and potential bias. Long term, our aim is for PeerCheck™ to serve as a model for how medical AI should be built and governed. The Benjamin Consulting Agreement has an initial term of November 2025 through May 15, 2028 and provides for compensation consisting of RSUs with an aggregate value of approximately $2,000,000 in consideration for the consulting services to be provided under the agreement. See “Compensation of Non-Employee Directors - Consulting Arrangements with Certain Directors” for additional information.”
Read it in the proxyopen_in_new
Limitation of Liability and Indemnification of Officers and Directors“Our amended and restated certificate of incorporation contains provisions that limit the liability of our directors for monetary damages to the fullest extent permitted by Delaware law. Consequently, our directors will not be personally liable to us or our stockholders for monetary damages for any breach of fiduciary duties as directors, except liability for the following:”
Read it in the proxyopen_in_new
Limitation of Liability and Indemnification of Officers and Directors“any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;”
Read it in the proxyopen_in_new
Limitation of Liability and Indemnification of Officers and Directors“any unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section 174 of the Delaware General Corporation Law; or • any transaction from which they derived an improper personal benefit.”
Read it in the proxyopen_in_new
Limitation of Liability and Indemnification of Officers and Directors“Any amendment to, or repeal of, these provisions will not eliminate or reduce the effect of these provisions in respect of any act, omission or claim that occurred or arose prior to that amendment or repeal. If the Delaware General Corporation Law is amended to provide for further limitations on the personal liability of directors of corporations, then the personal liability of our directors will be further limited to the greatest extent permitted by the Delaware General Corporation Law.”
Read it in the proxyopen_in_new
Limitation of Liability and Indemnification of Officers and Directors“In addition, our amended and restated bylaws provide that we will indemnify, to the fullest extent permitted by law, any person who is or was a party or is threatened to be made a party to any action, suit or proceeding by reason of the fact that he or she is or was one of our directors or officers or is or was serving at our request as a director or officer of another corporation, partnership, joint venture, trust or other enterprise. Our amended and restated bylaws provide that we may indemnify to the fullest extent permitted by law any person who is or was a party or is threatened to be made a party to any action, suit or proceeding by reason of the fact that he or she is or was one of our employees or agents or is or was serving at our request as an employee or agent of another corporation, partnership, joint venture, trust or other enterprise. Our amended and restated bylaws also provide that we must advance expenses incurred by or on behalf of a director or officer in advance of the final disposition of any action or proceeding, subject to very limited exceptions.”
Read it in the proxyopen_in_new
Limitation of Liability and Indemnification of Officers and Directors“Further, we have entered into indemnification agreements with each of our directors and executive officers that may be broader than the specific indemnification provisions contained in the Delaware General Corporation Law. These indemnification agreements require us, among other things, to indemnify our directors and executive officers against liabilities that may arise by reason of their status or service. These indemnification agreements also require us to advance all expenses incurred by the directors and executive officers in investigating or defending any such action, suit or proceeding. We believe that these agreements are necessary to attract and retain qualified individuals to serve as directors and executive officers.”
Read it in the proxyopen_in_new
Limitation of Liability and Indemnification of Officers and Directors“The limitation of liability and indemnification provisions that are included in our amended and restated certificate of incorporation, amended and restated bylaws and in indemnification agreements that we enter into with our directors and executive officers may discourage stockholders from bringing a lawsuit against our directors and executive officers for breach of their fiduciary duties. They may also reduce the likelihood of derivative litigation against our directors and executive officers, even though an action, if successful, might benefit us and other stockholders. Further, a stockholder’s investment may be harmed to the extent that we pay the costs of settlement and damage awards against directors and executive officers as required by these indemnification provisions. Apart from the disclosure under Part I, Item 3. “Legal Proceedings,” in our Annual Report on Form 10-K for fiscal year ended March 31, 2026, we are not aware of any pending litigation or proceeding involving any person who is or was one of our directors, officers, employees or other agents or is or was serving at our request as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, for which indemnification is sought, and we are not aware of any threatened litigation that may result in claims for indemnification.”
Read it in the proxyopen_in_new
Limitation of Liability and Indemnification of Officers and Directors“We maintain insurance policies under which, subject to the limitations of the policies, coverage is provided to our directors and executive officers against loss arising from claims made by reason of breach of fiduciary duty or other wrongful acts as a director or executive officer, including claims relating to public securities matters, and to us with respect to payments that may be made by us to these directors and executive officers pursuant to our indemnification obligations or otherwise as a matter of law.”
Read it in the proxyopen_in_new
Limitation of Liability and Indemnification of Officers and Directors“Certain of our non-employee directors may, through their relationships with their employers, be insured and/or indemnified against certain liabilities incurred in their capacity as members of our board.”
Read it in the proxyopen_in_new
Limitation of Liability and Indemnification of Officers and Directors“Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling our Company pursuant to the foregoing provisions, we have been informed that, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.”
Read it in the proxyopen_in_new
Procedures for Approval of Related Party Transactions“Our audit committee charter provides that the audit committee has the primary responsibility for reviewing and approving or disapproving “related party transactions,” which are transactions between us and related persons in which the aggregate amount involved exceeds or may be expected to exceed $120,000 and in which a related person has or will have a direct or indirect material interest. For purposes of this policy, a related person is defined as a director, executive officer, nominee for director or greater than 5% beneficial owner of our common stock, in each case since the beginning of the most recently completed year, and their immediate family members.”
Read it in the proxyopen_in_new
Procedures for Approval of Related Party Transactions“Certain of the transactions described above were entered into prior to the adoption of this policy. Accordingly, such transactions were approved by either the audit committee or the disinterested members of our board after making a determination that the transaction was executed on terms no less favorable than those that could have been obtained from an unrelated third party. Any related party transactions entered into after we adopted this policy were approved by our audit committee after making a determination that the transaction was executed on terms no less favorable than those that could have been obtained from an unrelated third party.”
Read it in the proxyopen_in_new
Paragraphs are compared by their words, not read by AI: one counts as new when no paragraph last year shares half of its words, or when it names a person or company last year's section did not. A deal reported again with a new amount is not new. Always check the filing. Open the proxy ↗ · Last year's proxy ↗
Sources
The related-party section (Item 404) of the latest annual proxy statement (DEF 14A), against last year's, compared by their words.
Also
CEO pay: the same proxy's pay versus performance table.
Work with it
Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/DOCS/export.csv") into a cell.